Dianthus Therapeutics (DNTH) Treasury Shares (2017 - 2023)

Dianthus Therapeutics' Treasury Shares history runs 7 years deep, the most recent figure standing at $63.0 for Q3 2023.

• On a quarterly basis, Treasury Shares changed N/A year-over-year to $63.0 in Q3 2023; TTM through Sep 2023 was $63.0, a N/A change from a year earlier, with the FY2022 full-year figure at $33.3 million, up 11398.52% from the prior year.
• Treasury Shares slipped to $63.0 in Q3 2023 per DNTH's latest filing, from $33.3 million in the prior quarter.
• Across five years, Treasury Shares topped out at $33.3 million in Q4 2022 and bottomed at $63.0 in Q3 2023.
• The 5-year median for Treasury Shares is $205722.0 (2019), against an average of $6.8 million.
• Across the five-year window, Treasury Shares sank 95.88% in 2020 and surged 11398.52% in 2022, its largest moves.
• Year by year, Treasury Shares stood at $205722.0 in 2019, then sank by 95.88% to $8466.0 in 2020, then soared by 3324.5% to $289918.0 in 2021, then jumped by 11398.52% to $33.3 million in 2022, then sank by 100.0% to $63.0 in 2023.
• Per Business Quant, the three latest DNTH Treasury Shares figures stand at $63.0 (Q3 2023), $33.3 million (Q4 2022), and $289918.0 (Q4 2021).